Audience Questions & Answers from RNL23 on Rheumatoid Arthritis
RNL23 was Sponsored by Abbvie – Thanks to Abbvie for their support of Rheumatology Education!
RA: Revolutionary Advances in Therapy This POD (session) devoted to advances in rheumatoid arthritis (RA) featured three excellent lectures:
- Dr. Kevin Deane – Preclinical RA – to Treat or not to treat
- Dr. Stanley Cohen – Year of the JAK inhibitors
- Dr. Michael Brenner - “Fibroblasts: Stromal Cells that hold exciting promise for treating RA.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.